Jyothy Labs

₹463 5.8 | 1.3%

WEBSITE BSE:532926 NSE : JYOTHYLAB 10 May, 16:01

Market Cap ₹17000 Cr.

Stock P/E 48.5

P/B 9.8

Current Price ₹463

Book Value ₹ 47.1

Face Value 1

52W High ₹554

Dividend Yield 0.65%

52W Low ₹ 200.6

Edit Ratio

Jyothy Labs Research see more...

Overview Inc. Year: 1992Industry: Household & Personal Products

Jyothy Labs Ltd, formerly Jyothy Laboratories Ltd, is a multi-logo, multi-product company focused on fast-moving consumer goods industry. It is engaged in manufacturing and advertising and marketing of material whiteners, mosquito repellents, scrubber, bodycare, soaps, detergents, and incense sticks. It operates thru 3 segments: Soaps and Detergents, which incorporates material whiteners, cloth detergents, dish wash bar and soaps, together with ayurvedic soaps; Home Care products, which includes incense sticks, scrubber, dhoop and mosquito repellents, and Others, which consists bodycare, tea and coffee. It merchandise are beneath numerous manufacturers, which comprises Fa, Neem, Fabric Spa, More light, Chek, Pril, Exo, Maxo, Margo, Henko, Mr. White, Ujala, Snoways, Busy easy and Wardrobe. Its subsidiaries are Four Seasons Drycleaning Company Pvt Ltd, Snoways Laundrers & Drycleaners Pvt Ltd, Jyothy Consumer Products Marketing Ltd, and Jyothy Fabricare Services Ltd.

Jyothy Labs Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Jyothy Labs Quarterly Results

#(Fig in Cr.)	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
Net Sales	585	539	547	597	659	613	617	687	732	678
Other Income	5	4	6	13	5	15	6	17	13	11
Total Income	590	543	552	610	665	628	623	704	746	688
Total Expenditure	519	478	489	537	579	528	526	570	597	559
Operating Profit	71	65	63	73	86	100	97	134	149	129
Interest	3	3	3	3	3	3	3	1	1	1
Depreciation	14	14	15	13	13	12	12	12	12	13
Exceptional Income / Expenses	0	0	0	0	7	0	0	0	0	0
Profit Before Tax	55	47	45	57	76	84	82	121	135	115
Provision for Tax	11	9	8	9	11	17	23	25	31	24
Profit After Tax	44	38	37	48	65	67	59	96	104	91
Adjustments	1	0	1	1	-1	0	-0	0	0	-0
Profit After Adjustments	45	38	38	48	65	67	59	96	104	91
Adjusted Earnings Per Share	1.2	1	1	1.3	1.8	1.8	1.6	2.6	2.8	2.5

Jyothy Labs Profit & Loss

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	TTM
Net Sales	1107	1324	1515	1593	1683	1672	1814	1711	1909	2196	2486	2714
Other Income	4	8	10	14	11	62	28	20	18	19	40	47
Total Income	1111	1332	1525	1607	1694	1735	1841	1731	1928	2215	2526	2761
Total Expenditure	1019	1168	1352	1371	1429	1415	1532	1460	1595	1948	2170	2252
Operating Profit	92	164	173	236	265	320	309	271	333	267	355	509
Interest	68	55	14	62	56	48	35	33	19	12	13	6
Depreciation	22	24	33	31	30	31	31	53	56	58	50	49
Exceptional Income / Expenses	0	-2	-2	0	0	0	0	-4	-24	0	7	0
Profit Before Tax	1	82	125	143	179	241	243	182	235	197	299	453
Provision for Tax	-15	1	4	69	-26	62	45	19	44	38	59	103
Profit After Tax	16	81	121	74	204	179	198	163	191	159	240	350
Adjustments	4	0	0	4	4	7	7	8	9	3	0	0
Profit After Adjustments	20	81	121	78	208	186	205	170	199	162	240	350
Adjusted Earnings Per Share	0.6	2.2	3.3	2.2	5.7	5.1	5.6	4.6	5.4	4.4	6.5	9.5

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	13%	13%	8%	8%
Operating Profit CAGR	33%	9%	2%	14%
PAT CAGR	51%	14%	6%	31%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	128%	47%	24%	17%
ROE Average	16%	14%	14%	14%
ROCE Average	20%	17%	16%	14%

Jyothy Labs Balance Sheet

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Shareholder's Funds	639	734	780	901	1089	1144	1327	1229	1429	1444	1549
Minority's Interest	5	2	1	-3	-7	-14	-21	-29	-38	-41	2
Borrowings	427	527	449	7	6	4	2	0	0	0	0
Other Non-Current Liabilities	11	207	245	158	54	121	176	236	243	293	336
Total Current Liabilities	437	299	438	843	774	848	630	592	554	595	505
Total Liabilities	1518	1769	1913	1907	1916	2103	2114	2027	2187	2291	2392
Fixed Assets	1062	1094	1074	1068	1097	1091	1101	1149	1147	1122	1116
Other Non-Current Assets	106	190	266	345	306	312	347	382	335	370	402
Total Current Assets	349	485	573	494	512	700	666	496	706	799	874
Total Assets	1518	1769	1913	1907	1916	2103	2114	2027	2187	2291	2392

Jyothy Labs Cash Flow

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Opening Cash & Cash Equivalents	44	19	95	26	24	40	62	75	15	72	76
Cash Flow from Operating Activities	28	130	166	192	163	242	302	171	402	203	329
Cash Flow from Investing Activities	-28	-91	-26	108	-17	-74	30	72	-129	-32	-48
Cash Flow from Financing Activities	-24	37	-18	-302	-130	-145	-318	-304	-216	-167	-251
Net Cash Inflow / Outflow	-25	76	123	-2	16	23	13	-60	57	4	30
Closing Cash & Cash Equivalent	19	95	218	24	40	63	75	15	72	76	106

Jyothy Labs Ratios

#	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Earnings Per Share (Rs)	0.61	2.25	3.35	2.16	5.73	5.12	5.59	4.64	5.43	4.41	6.53
CEPS(Rs)	1.19	2.91	4.24	2.9	6.45	5.78	6.21	5.87	6.71	5.92	7.89
DPS(Rs)	2.5	3	4	5	6	0.5	3	3	4	2.5	3
Book NAV/Share(Rs)	18.08	20.28	20.74	23.74	29.04	30.59	36.12	33.46	38.9	39.31	42.18
Core EBITDA Margin(%)	7.59	11.35	10.4	13.38	14.55	15.23	12.95	12.19	13.51	9.32	10.46
EBIT Margin(%)	6.02	10.01	8.82	12.35	13.44	17.09	12.82	10.41	10.9	7.84	10.34
Pre Tax Margin(%)	0.11	5.97	7.94	8.62	10.21	14.24	11.2	8.81	10.08	7.4	9.91
PAT Margin (%)	1.4	5.93	7.72	4.45	11.67	10.58	9.1	7.89	8.19	5.98	7.94
Cash Profit Margin (%)	3.34	7.7	9.79	6.34	13.39	12.42	10.51	10.46	10.57	8.16	9.6
ROA(%)	1.1	4.94	6.57	3.87	10.68	8.9	9.37	7.85	9.05	7.11	10.24
ROE(%)	2.69	12.33	16.29	9.16	21.32	16.51	16.2	12.73	14.35	11.08	16.02
ROCE(%)	5.68	10.81	10.57	15.17	16	17.63	16.89	13.75	16.61	13.4	20.03
Receivable days	25.47	19.61	14.47	16.66	22.04	30	26.41	24.43	16.99	16.27	16.98
Inventory Days	46.51	46.08	41.8	40.72	39.8	41.54	32.85	37.86	39.48	39.47	36.22
Payable days	86.6	61.75	57.43	64.1	63.3	62.5	61.97	62.51	58.11	60.94	57.33
PER(x)	136	46.24	39.96	67.18	31.19	38.18	32.68	20.21	25.2	33.45	29.26
Price/Book(x)	4.58	5.13	6.44	6.1	6.15	6.39	5.05	2.8	3.52	3.75	4.53
Dividend Yield(%)	1.51	1.44	1.5	1.73	1.68	0.13	1.64	3.2	2.92	1.69	1.57
EV/Net Sales(x)	2.94	3.19	3.52	3.54	4.09	4.49	3.8	2.16	2.59	2.43	2.71
EV/Core EBITDA(x)	35.43	25.83	30.85	23.84	25.97	23.48	22.29	13.64	14.86	19.98	18.94
Net Sales Growth(%)	21.16	19.64	14.43	5.14	5.67	-0.63	8.44	-5.65	11.57	15.05	13.18
EBIT Growth(%)	-15.47	97.4	0.86	48.19	14.72	22.83	-3.65	-22.95	18.41	-17.78	49.63
PAT Growth(%)	-58.06	404.14	48.97	-38.98	176.55	-12.38	10.47	-17.72	17.27	-16.53	50.65
EPS Growth(%)	-55.93	269.21	48.75	-35.58	165.74	-10.65	9.14	-16.94	17.09	-18.79	48.01
Debt/Equity(x)	1.08	0.73	0.76	0.52	0.47	0.49	0.21	0.23	0.08	0.09	0
Current Ratio(x)	0.8	1.62	1.31	0.59	0.66	0.83	1.06	0.84	1.27	1.34	1.73
Quick Ratio(x)	0.41	1.04	0.89	0.37	0.41	0.6	0.74	0.46	0.77	0.84	1.13
Interest Cover(x)	1.02	2.48	10.04	3.31	4.16	6.01	7.9	6.52	13.2	17.68	23.86
Total Debt/Mcap(x)	0.24	0.14	0.12	0.09	0.08	0.08	0.04	0.08	0.02	0.02	0

Jyothy Labs Shareholding Pattern

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	62.89	62.89	62.89	62.89	62.89	62.89	62.89	62.89	62.89	62.89
FII	9.94	10.89	11.47	12.8	13.37	13.77	13.97	14.62	14.65	16.43
DII	18.3	16.9	18.14	17.48	17.13	16.82	15.36	14.12	13.85	13.29
Public	8.87	9.32	7.5	6.84	6.61	6.53	7.78	8.36	8.61	7.39
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	23.09	23.09	23.09	23.09	23.09	23.09	23.09	23.09	23.09	23.09
FII	3.65	4	4.21	4.7	4.91	5.05	5.13	5.37	5.38	6.03
DII	6.72	6.21	6.66	6.42	6.29	6.18	5.64	5.19	5.09	4.88
Public	3.26	3.42	2.75	2.51	2.43	2.4	2.86	3.07	3.16	2.71
Others	0	0	0	0	0	0	0	0	0	0
Total	36.72	36.72	36.72	36.72	36.72	36.72	36.72	36.72	36.72	36.72

Pros

Debtor days have improved from 60.94 to 57.33days.
Company is almost debt free.

Cons

Company has a low return on equity of 14% over the last 3 years.
Stock is trading at 9.8 times its book value.
The company has delivered a poor profit growth of 6% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.